Cerity Partners
EXAS

Cerity Partners’s Exact Sciences EXAS Stock Holding History

Cerity Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125,318
Closed -$12.7M – 3295
2025
Q4 		$12.7M Buy
125,318
+64,140
+105% +$5.15M 0.02% 549
2025
Q3 		$3.35M Buy
61,178
+22,308
+57% +$1.11M 0.01% 1050
2025
Q2 		$2.07M Buy
38,870
+5,272
+16% +$268K ﹤0.01% 1203
2025
Q1 		$1.45M Buy
33,598
+6,508
+24% +$330K ﹤0.01% 1262
2024
Q4 		$1.54M Buy
27,090
+10,761
+66% +$670K ﹤0.01% 1220
2024
Q3 		$1.11M Buy
16,329
+10,772
+194% +$608K ﹤0.01% 1349
2024
Q2 		$235K Sell
5,557
-2,100
-27% -$116K ﹤0.01% 1948
2024
Q1 		$529K Buy
7,657
+2,425
+46% +$153K ﹤0.01% 1572
2023
Q4 		$387K Buy
+5,232
New +$343K ﹤0.01% 1391
2023
Q3 		– Sell
-8,439
Closed -$792K – 1490
2023
Q2 		$792K Buy
8,439
+252
+3% +$19.7K ﹤0.01% 997
2023
Q1 		$555K Buy
8,187
+2,174
+36% +$140K ﹤0.01% 1248
2022
Q4 		$298K Buy
+6,013
New +$246K ﹤0.01% 1143
2022
Q2 		– Sell
-5,189
Closed -$362K – 1201
2022
Q1 		$362K Sell
5,189
-787
-13% -$57.5K 0.01% 674
2021
Q4 		$463K Buy
5,976
+792
+15% +$69.9K 0.01% 619
2021
Q3 		$495K Sell
5,184
-297
-5% -$31.4K 0.01% 469
2021
Q2 		$681K Buy
5,481
+227
+4% +$27.1K 0.01% 420
2021
Q1 		$692K Buy
5,254
+2,265
+76% +$310K 0.02% 392
2020
Q4 		$396K Buy
2,989
+735
+33% +$88.9K 0.01% 454
2020
Q3 		$230K Buy
+2,254
New +$195K 0.01% 443
2020
Q1 		– Sell
-2,163
Closed -$200K – 467
2019
Q4 		$200K Sell
2,163
-252
-10% -$22.2K 0.01% 507
2019
Q3 		$218K Sell
2,415
-77
-3% -$8.77K 0.01% 442
2019
Q2 		$294K Sell
2,492
-1,128
-31% -$114K 0.02% 403
2019
Q1 		$314K Sell
3,620
-503
-12% -$42.8K 0.02% 410
2018
Q4 		$260K Buy
+4,123
New +$283K 0.02% 430

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Cerity Partners's EXAS Position: Q1 2026 in Review

Cerity Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 125,318 shares — an estimated $12.7M sold.

Cerity Partners first reported a position in EXAS in Q4 2018 and held it in 24 quarters. The position peaked at $12.7M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cerity Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 125,318 Exact Sciences shares in Q1 2026, an estimated $12.7M.
  • Cerity Partners first reported a position in Exact Sciences in Q4 2018 and held it in 24 quarters.
  • Cerity Partners's Exact Sciences position peaked at $12.7M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.